Determining the health needs and outcomes of key populations of people who use drugs

Investigators: ProfPaul Dietze, Prof Lisa Maher, Prof Matthew Hickman, Prof Thomas Keer, Prof Mark Stoove, Prof Joseph Doyle, A/Prof Bernadette Ward, Jocelyn Jones, A/Prof Paul Agius, A/Prof James Trauer

Funder: NHMRC

Injecting drug use and methamphetamine smoking are the two forms of drug use linked to the majority of illicit drug related harm in Australia. We will establish a new cohort study to establish how these types of drug use evolve and how interventions such as supervised injecting facilities and drug treatment work to reduce harm. Our findings will inform priority responses to prevent associated drug-related harms in a changing social, health and service delivery environment over the coming decade.

This project is a collaboration between Burnet Institute, University of New South Wales, University of Bristol, University of British Columbia, Department of Infections Diseases, School of Rural Health, Biostatistics, Data Analytics/Modelling and Health Economics, Monash Addiction Research Centre, Deakin University